Stay updated with breaking news from Key Anticipated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data...
Announced promising preliminary clinical data for OTX-2002 from ongoing MYCHELANGELO™ I trial; clinical proof-of-platform established with potenti...
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Department of Defense recently announced at a Cybersecurity Maturity Model Certification Day conference it expects to complete documentation to submit to the Office of Management and Budget OMB for the rulemaking process by July 2022,and interim final rules by March 2023.
Anyone who has been closely following the Department of Defense’s (DoD) Cybersecurity Maturity Model Certification (CMMC) program knows the effort…